Latest News and Press Releases

Press Release 4BIO Capital Leads $6 Million Seed Financing in Ray Therapeutics 4 January 2022 LONDON & BOSTON – 4BIO Capital (“4BIO” or “the Group”), an international venture capital firm...

Press Release 4BIO Capital Leads $6 Million Seed Financing in Ray Therapeutics 4 January 2022 LONDON & BOSTON – 4BIO Capital (“4BIO” or “the Group”), an international venture capital firm...

4BIO Capital Announces Strategic Partnership with Harbor Capital Advisors 4BIO Capital appointed as highly specialized asset manager for Harbor’s disruptive innovation strategy after competitive...

Press Release 4BIO Capital Co-leads $10 Million Seed Financing in Code Biotherapeutics 20 April 2021 LONDON & BOSTON – 4BIO Capital (“4BIO” or “the Group”), an international venture capital...

Press Release 4BIO Capital Joins Investor Syndicate in CARISMA Therapeutics’ Second Closing of $59 Million Series B Round 1 March 2021 LONDON & BOSTON – 4BIO Capital (“4BIO” or “the Group”),...

Press Release 4BIO Capital’s review of AAV gene therapy clinical trials published in Nature Reviews Drug Discovery Systematic review and meta-analysis of 149 clinical trials of AAV-based gene...

Appointment of Professor Akiko Iwasaki to Scientific Advisory Board Professor of Molecular, Cellular and Developmental Biology and Immunology at Yale UniversityPrincipal investigator at the Howard...

Appointment of Professor Akiko Iwasaki to Scientific Advisory Board Professor of Molecular, Cellular and Developmental Biology and Immunology at Yale UniversityPrincipal investigator at the Howard...

Press Release 4BIO Capital leads SparingVision’s €44.5 million financing round 21 October 2020 LONDON & BOSTON – 4BIO Capital (“4BIO” or “the Group”), an international venture capital firm...

Press Release 4BIO Capital leads SparingVision’s €44.5 million financing round 21 October 2020 LONDON & BOSTON – 4BIO Capital (“4BIO” or “the Group”), an international venture capital firm...